Retraction Note to: Cancer Cell Int (2019) 19:75
The Editors-in-Chief retracted this article because of concerns regarding a number of figures presented in this work. These concerns call into question the article’s overall scientific soundness. An investigation conducted after its publication discovered similarities between images in this work:
-
The panel labelled sh-control in Fig. 3C overlaps with the panel labelled sh-control in Fig. 3D, after a 90º rotation.
-
The Beta-actin band in Fig. 4G overlaps with a portion of the Beta-actin band in Fig. 2G, after a horizontal flip and a change in scale.
The Editors-in-Chief therefore no longer have confidence in the integrity of the research presented in this article. The authors have not replied to correspondence from the Publisher.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The online version of the original article can be found at https://doi.org/10.1186/s12935-019-0791-4.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Pei, J., Zhang, J., Yang, X. et al. Retraction Note: TMED3 promotes cell proliferation and motility in breast cancer and is negatively modulated by miR-188-3p. Cancer Cell Int 24, 128 (2024). https://doi.org/10.1186/s12935-024-03310-8
Accepted:
Published:
DOI: https://doi.org/10.1186/s12935-024-03310-8